Free Trial

HUTCHMED (HCM) Competitors

HUTCHMED logo
GBX 263 +9.00 (+3.54%)
As of 12:31 PM Eastern

HCM vs. ITH, SOPH, GRI, INDV, SLS, ERGO, SLN, AMYT, BMY, and OGN

Should you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Ithaca Energy (ITH), Sophos Group plc (SOPH.L) (SOPH), Grainger (GRI), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

HUTCHMED vs. Its Competitors

Ithaca Energy (LON:ITH) and HUTCHMED (LON:HCM) are both mid-cap energy companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk.

Ithaca Energy has a net margin of 6.48% compared to HUTCHMED's net margin of -6.87%. Ithaca Energy's return on equity of 4.55% beat HUTCHMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Ithaca Energy6.48% 4.55% 0.18%
HUTCHMED -6.87%-5.71%-5.90%

In the previous week, Ithaca Energy had 7 more articles in the media than HUTCHMED. MarketBeat recorded 8 mentions for Ithaca Energy and 1 mentions for HUTCHMED. Ithaca Energy's average media sentiment score of 1.01 beat HUTCHMED's score of 0.26 indicating that Ithaca Energy is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ithaca Energy
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HUTCHMED
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

HUTCHMED received 195 more outperform votes than Ithaca Energy when rated by MarketBeat users. Likewise, 78.40% of users gave HUTCHMED an outperform vote while only 25.00% of users gave Ithaca Energy an outperform vote.

CompanyUnderperformOutperform
Ithaca EnergyOutperform Votes
1
25.00%
Underperform Votes
3
75.00%
HUTCHMEDOutperform Votes
196
78.40%
Underperform Votes
54
21.60%

3.7% of Ithaca Energy shares are owned by institutional investors. Comparatively, 36.5% of HUTCHMED shares are owned by institutional investors. 89.6% of Ithaca Energy shares are owned by insiders. Comparatively, 39.0% of HUTCHMED shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Ithaca Energy has higher revenue and earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Ithaca Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ithaca Energy£3.55B0.91£230.29M£8.7617.70
HUTCHMED£771.01M3.70-£52.98M-£3.92-67.13

Summary

Ithaca Energy beats HUTCHMED on 10 of the 14 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCM vs. The Competition

MetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.86B£2.16B£5.60B£2.93B
Dividend Yield4.63%2.92%5.28%4.90%
P/E Ratio-67.134.0227.22125.77
Price / Sales3.70623.49408.95243,030.60
Price / Cash2.4910.2538.2528.07
Price / Book3.017.207.114.76
Net Income-£52.98M£20.70B£3.24B£5.91B
7 Day Performance17.41%-0.48%2.47%6.94%
1 Month Performance22.90%4.54%8.66%16.70%
1 Year Performance-6.07%105.21%31.22%78.32%

HUTCHMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCM
HUTCHMED
N/AGBX 263
+3.5%
N/A-10.2%£2.86B£771.01M-67.131,760Gap Up
High Trading Volume
ITH
Ithaca Energy
N/AGBX 144.40
+0.3%
N/A+16.9%£3.01B£3.55B16.49220Positive News
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
GRI
Grainger
3.3628 of 5 stars
GBX 215.50
-0.7%
GBX 317.50
+47.3%
-7.3%£1.59B£276.05M-1,436.67372News Coverage
Dividend Increase
Gap Up
INDV
Indivior
2.1284 of 5 stars
GBX 984.50
+3.3%
GBX 1,650
+67.6%
-22.7%£1.54B£1.40B-816.291,000
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100News Coverage
High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
2.621 of 5 stars
GBX 522.30
+0.2%
GBX 825
+58.0%
-15.5%£421.46M£382.40M11.1734,300
OGN
Origin Enterprises
N/AGBX 3.52
-0.1%
N/A+17.4%£371.67M£183.08B10.1810,000Dividend Increase
High Trading Volume

Related Companies and Tools


This page (LON:HCM) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners